Brian Geller, MD
Vascular & Interventional Radiology · Gainesville, FLNPI 1336100544
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.0%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 64.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $9,440 and has fallen 68.0% since, to $3,021 in 2025.
Across 115 payments — averaging $152.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$11K
- Biocompatibles, Inc.$5K
- Penumbra, Inc.$663
- Biocompatibles UK Ltd$200
- Medtronic$178
- Johnson & Johnson$123
- plus $188 from 4 others
Across 2 payments — averaging $8222.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biocompatibles UK Ltd$16K
What the payments were for
- Consulting fees$8,61349%
- Speaking & faculty fees$1,3758%
- Travel & lodging$1,0076%
- Food & beverage$6,59337%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 90 | $11,331 |
| Biocompatibles, Inc. | 7 | $4,905 |
| Penumbra, Inc. | 10 | $663 |
| Biocompatibles UK Ltd | 1 | $200 |
| Medtronic | 2 | $178 |
| Johnson & Johnson | 1 | $123 |
| Terumo Medical Corporation | 1 | $106 |
| Inari Medical, Inc. | 1 | $50 |
| W. L. Gore & Associates, Inc. | 1 | $21 |
| Argon Medical Devices, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THERASPHERE-BIO$4,800
- GENERAL VASCULAR INTERVENTION$3,450
- TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)$2,525
- GENERAL - THERAPIES$903
- EMBOLD Fibered$653
- TRUSELECT$391
- GENERAL - IO ABLATION$366
- GENERAL EMBOLICS$266
- RUBY Coil$264
- LC BEAD$200
- Abre$161
- THERASPHERE$133
- GENERAL CATHETERS$124
- Certus 140$123
- Indigo System$123
- DIREXION$119
- SPYGLASS$119
- Indigo$111
- AZUR$106
How this compares
$17,588 in reported general payments places this provider in the 75th percentile of 329 vascular & interventional radiology providers in Florida.
See all vascular & interventional radiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular & interventional radiology in Gainesville
- Bret WiechmannGainesville$1.3M
- Robert HeithausGainesville$152K
- Ripal GandhiMiami$2.5M
- Michael CohnHollywood$1.3M
- George OliveiraMiami$666K
- Fakhir ElmasriLakeland$563K
- Shaun PatelCoral Gables$458K
- Justin LeeTampa$408K
- Timothy YatesMiami Beach$392K
- Rishi RazdanJacksonville$378K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.